Rossella Belleli
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Systematic Literature Review to Identify Cost and Resource Use Data in Patients with Early-Stage Non-small Cell Lung Cancer (NSCLC).
Journal: PharmacoEconomics
Published: June 11, 2023
Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 17, 2023
Survival and quality-of-life outcomes in early-stage NSCLC patients: a literature review of real-world evidence.
Journal: Lung cancer management
Published: March 02, 2023
Cost-effectiveness analysis of adjuvant atezolizumab in stage II-IIIA non-small cell lung cancer expressing ≥50% PD-L1: A United Kingdom health care perspective.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 14, 2022
Treatment patterns and survival of patients with locoregional recurrence in early-stage NSCLC: a literature review of real-world evidence.
Journal: Medical oncology (Northwood, London, England)
Published: June 06, 2022
A Network Meta-Analysis of Cancer Immunotherapies Versus Chemotherapy for First-Line Treatment of Patients With Non-Small Cell Lung Cancer and High Programmed Death-Ligand 1 Expression.
Journal: Frontiers in oncology
Published: March 05, 2021
A Database Cohort Study to Assess the Risk of Angioedema Among Patients with Heart Failure Initiating Angiotensin-Converting Enzyme Inhibitors in the USA.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions
Published: November 28, 2017
A nonparametric method to detect increased frequencies of adverse drug reactions over time.
Journal: Statistics in medicine
Published: September 20, 2016
Regulatory watch: Efficiency indicators for new drugs approved by the FDA from 2003 to 2013.
Journal: Nature reviews. Drug discovery
Published: February 28, 2015
Assessing switchability for biosimilar products: modelling approaches applied to children's growth.
Journal: Pharmaceutical statistics
Published: May 16, 2014
AXT914 a novel, orally-active parathyroid hormone-releasing drug in two early studies of healthy volunteers and postmenopausal women.
Journal: Bone
Published: December 06, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026